# SPIRONOLACTONE
> **ANDA219494** · Abbreviated New Drug Application (Generic) · Sponsor: GRAVITI PHARMS · Approved 2025-01-23
## Drug
- **FDA Application Number:** ANDA219494
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SPIRONOLACTONE
- **Generic name:** SPIRONOLACTONE
- **Active ingredients:** SPIRONOLACTONE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GRAVITI PHARMS
- **Manufacturer:** Rising Pharma Holdings, Inc.
- **First approval:** 2025-01-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219494)
---
*MORVS · CC0 1.0*